Medically reviewed by Kashif J. Piracha, MD Most people have two kidneys, and kidney failure is a serious and dangerous ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

Clinicians treating patients with kidney disease must be aware of dental considerations to avoid potentially lethal consequences.

Researchers at University of Tsukuba have found that the phosphate concentration in proximal tubule fluid, estimated from ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

Top data on glomerular disease presented at the 2024 American Society of Nephrology Kidney Week conference include data on atacicept benefits in IgA nephropathy, protein reduction from ...

The Food and Drug Administration (FDA) has added a new boxed warning on the denosumab drug label (brand name: Prolia) to alert clinicians to an increased risk for severe hypocalcemia in patients with ...

Diabetes-related kidney disease is a rapidly growing crisis in India ... Many people with diabetes in India don’t get tested ...

Fortis Gurugram is committed to delivering world-class healthcare to the patients and supporting the fight against chronic ...